PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS

Abstract

pharmacoeconomic study of treatment primary open-angle glaucoma with combinations of prostaglandin analogues and beta-blockers by mean of cost-efficacy and budget impact analysis. Results have shown, that Duotrav (travoprost+timolol) has benefits compare with Xalacom (latanoprost+timolol) from cost-efficacy perspective and can be claimed dominant. Futhermore Doutrav in comparison with Xalacom provides cost-saving and advantage in terms of budget impact analysis

Keywords

• primary open-angle glaucoma
• pharmacoeconomic studies
• cost-efficacy analysis
• budget impact analysis
• duotrav
• xalacom
• travoprost
• latanoprost
• timolol